Modelling melanoma in mice.

作者: Graeme J. Walker , H. P. Soyer , Tamara Terzian , Neil F. Box

DOI: 10.1111/J.1755-148X.2011.00923.X

关键词:

摘要: Phenotypic and molecular heterogeneity in human melanoma has impaired efforts to explain many of the clinically important features melanoma. For example, underlying mechanisms that might predict age-of-onset, time metastasis other key elements progression remain unknown. Furthermore, staging used outcome treatment not yet moved beyond a basic phenotypic classification. While molecularly targeted therapies show great promise for patients, establishing accurate animal models recapitulate cutaneous remains priority. We examine relevance mice as histopathologic variants These may be preclinical probe relationships between causative mutations, disease therapeutics. ask how new mouse models, or more detailed analyses existing advance our understanding genotype-phenotype correlations this tumour type. This necessarily involves consideration utility ultraviolet radiation-induced melanoma, improved.

参考文章(158)
Carlynn Willmore-Payne, Joseph A. Holden, Sharon Hirschowitz, Lester J. Layfield, BRAF and c-kit gene copy number in mutation-positive malignant melanoma. Human Pathology. ,vol. 37, pp. 520- 527 ,(2006) , 10.1016/J.HUMPATH.2006.01.003
Yuwaraj Kadariya, Bu Yin, Baiqing Tang, Susan A. Shinton, Eoin P. Quinlivan, Xiang Hua, Andres Klein-Szanto, Tahseen I. Al-Saleem, Craig H. Bassing, Richard R. Hardy, Warren D. Kruger, Mice heterozygous for germ-line mutations in methylthioadenosine phosphorylase (MTAP) die prematurely of T-cell lymphoma. Cancer Research. ,vol. 69, pp. 5961- 5969 ,(2009) , 10.1158/0008-5472.CAN-09-0145
Lyubomir T Vassilev, Binh T Vu, Bradford Graves, Daisy Carvajal, Frank Podlaski, Zoran Filipovic, Norman Kong, Ursula Kammlott, Christine Lukacs, Christian Klein, Nader Fotouhi, Emily A Liu, In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science. ,vol. 303, pp. 844- 848 ,(2004) , 10.1126/SCIENCE.1092472
T. Terzian, Y.-A. Suh, T. Iwakuma, S. M. Post, M. Neumann, G. A. Lang, C. S. Van Pelt, G. Lozano, The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss Genes & Development. ,vol. 22, pp. 1337- 1344 ,(2008) , 10.1101/GAD.1662908
Carol Beadling, Erick Jacobson-Dunlop, F. Stephen Hodi, Claudia Le, Andrea Warrick, Janice Patterson, Ajia Town, Amy Harlow, Frank Cruz, Sharl Azar, Brian P. Rubin, Susan Muller, Rob West, Michael C. Heinrich, Christopher L. Corless, KIT Gene Mutations and Copy Number in Melanoma Subtypes Clinical Cancer Research. ,vol. 14, pp. 6821- 6828 ,(2008) , 10.1158/1078-0432.CCR-08-0575
Kelly A McGowan, Jun Z Li, Christopher Y Park, Veronica Beaudry, Holly K Tabor, Amit J Sabnis, Weibin Zhang, Helmut Fuchs, Martin Hrabé de Angelis, Richard M Myers, Laura D Attardi, Gregory S Barsh, Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects Nature Genetics. ,vol. 40, pp. 963- 970 ,(2008) , 10.1038/NG.188
Jürgen Bauer, Petra Büttner, Rajmohan Murali, Ichiro Okamoto, Nicholas A. Kolaitis, Maria T. Landi, Richard A. Scolyer, Boris C. Bastian, BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor and the degree of solar elastosis at the primary tumor site Pigment Cell & Melanoma Research. ,vol. 24, pp. 345- 351 ,(2011) , 10.1111/J.1755-148X.2011.00837.X
Donata Rimoldi, Danielle Liénard, Jean-Charles Cerottini, Ferdy J Lejeune, Leonidas Zografos, Daniel Speiser, Suzanne Salvi, Lack of BRAF mutations in uveal melanoma. Cancer Research. ,vol. 63, pp. 5712- 5715 ,(2003)